<DOC>
	<DOC>NCT01557712</DOC>
	<brief_summary>The objective of this study is to evaluate the effectiveness of ketamine (infusion of 0.5mg/kg) and venlafaxine compared to the use of venlafaxine alone in the treatment of major depression (MADRS score ≥ 20 ) to six weeks of treatment.</brief_summary>
	<brief_title>Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients aged 18 or over, Introducing a single depressive episode or recurrent unipolar Responding to the diagnosis of severe major depressive episode according to DSM IV (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition): MADRS score ≥ 20, absence of treatment with ketamine for analgesia or anesthesia during the last 6 months Affiliate (or beneficiary) to a social security system Informed consent signed Contraindication to ketamine administration or treatment with venlafaxine; Failure of treatment with venlafaxine in the current episode (as low as 150 mg for 15 days); Axis I diagnosis according to DSM IV bipolar disorder (type I, II or III), schizoaffective disorder, schizophrenia, alcohol and other toxic or weaned for at least 6 months; Current Episode resistant stage V according to the classification of Thase and Rush (failed a course of bilateral ECT); Major depressive episode with severity criteria (significant risk of suicide is a MADRS score ≥ 5SI; decubitus complications, intravenous hydration); episode currently being treated with fluoxetine; Patients hospitalized without their consent or measure of legal protection (guardianship, curatorship); Affection Organic likely to affect cognitive abilities and brain structures (eg, HIV, MS, lupus, Parkinson's disease, epilepsy, dementia ...) or decompensation; Pregnancy or breastfeeding underway.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>